Company Overview and News

6
Electronics Components Outlook: Growth Inherent Amid Trade Spat

2018-09-19 zacks
The Zacks Electronics - Miscellaneous Components industry comprises an array of companies with diversified end markets. Moreover, apart from the United States, a number of companies in this industry are domiciled in Japan, Germany, the Netherlands and Switzerland. The industry is benefiting from strong end-market demand, particularly from automotive, portable devices, display (LED & LCD), medical devices and hardware markets.
AVX KEM CTS 4345 VPG.WI VPG

7
5 Tech Stocks Momentum Investors Should Buy Right Now

2018-08-23 zacks
The growing influence of technology in our day-to-day life is reminiscent of Albert Einstein’s famous remark, “It has become appallingly obvious that our technology has exceeded our humanity.” The rapid evolution of technology has invaded every facet of our lives from the wrist watch one wears to the cars we drive; it comes down to an all-encompassing age of digitization.
SOJA STZ.B SO QRVO VPG.WI A GRMN PCTY STZ VPG

 
Vishay (VPG) Hits Fresh High: Is There Still Room to Run?

2018-08-22 zacks
Have you been paying attention to shares of Vishay (VPG - Free Report) ? Shares have been on the move with the stock up 13.4% over the past month. VPG hit a new 52-week high of $44.9 in the previous session. Vishay has gained 76.9% since the start of the year compared to the 10.1% move for the Zacks Computer and Technology sector and the 3.2% return for the Zacks Electronics - Miscellaneous Components industry.
CSWI VPG.WI FN VPG

 
Vishay Precision Group, Inc. (VPG) CEO Ziv Shoshani on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Vishay Precision Group, Inc. (NYSE:VPG) Q2 2018 Earnings Conference Call August 7, 2018 10:00 AM ET
VPG.WI VPG

 
Vishay Precision (VPG) Presents At Jefferies 14th Annual Industrials Conference - Slideshow

2018-08-09 seekingalpha
The following slide deck was published by Vishay Precision Group, Inc. in conjunction with this event.
VPG.WI VPG

 
Vishay Precision Group, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-07 seekingalpha
The following slide deck was published by Vishay Precision Group, Inc. in conjunction with their 2018 Q2 earnings call.
VPG.WI VPG

17
Stoneridge (SRI) Soars to 52-Week High, Time to Cash Out?

2018-06-27 zacks - 1
Have you been paying attention to shares of Stoneridge (SRI - Free Report) ? Shares have been on the move with the stock up 18% over the past month. SRI hit a new 52-week high of $37.20 in the previous session. Stoneridge has gained 60.9% since the start of the year compared to the 5.7% move for the Computer and Technology sector and the -5.6% year-to-date return for its peer group.
VPG.WI PVAC PVAYQ TEL PVA SRI LNR NOVT VPG

36
Ballard (BLDP) Unit to Supply SPM-622 Kits to U.S. Army

2018-06-26 zacks
Ballard Power Systems (BLDP - Free Report) has announced that its unit Protonex has received a $1.0 million order to supply SPM-622 Squad Power Manager Kits to support U.S. Army brigades deploying overseas. The waterproof SPM-622 Squad Power Manager works as a universal power hub and automatic voltage converter, lowering battery burden and supporting missions in harsh environment. The SPM-622 Squad Power Manager system’s ability to convert and manage the power that the unit is drawing or passing through makes it unique and helps today’s warfighter to manage energy between batteries and electronic equipment.
BLD VPG.WI IEC SRI BLDP VPG

179
Apple Roundup: Kids Content, Repair Issues, Qualomm, Pay

2018-06-26 zacks - 1
Apple (AAPL - Free Report) news from last week included its push into kids’ original programming, issues related to its repair and replace policy, a counter-aggressive measure in its patent infringement case versus Qualcomm (QCOM - Free Report) and more. Here are the details-
HHPG MTCH HHPD VRNT VPG.WI AAPL QCOM MCHP VPG

8
Verdad's Four Small Cap "Picks" Are All Up By 61.1% Over The Past Year

2018-06-26 valuewalk
It has been claimed that value investing is dead, and the value principles that helped make Warren Buffett his first $1 million, no longer apply.
VPG.WI 4028 XAN RSO VPG

28
Stoneridge (SRI) Hits Fresh High: Is There Still Room to Run?

2018-06-26 zacks
Have you been paying attention to shares of Stoneridge (SRI - Free Report) ? Shares have been on the move with the stock up 18% over the past month. SRI hit a new 52-week high of $37.20 in the previous session. Stoneridge has gained 60.9% since the start of the year compared to the 5.7% move for the Computer and Technology sector and the -5.6% year-to-date return for its peer group.
VPG.WI WLL PVAC PVAYQ TEL PVA SRI LNR NOVT VPG

113
Vishay Precision (VPG) Hits Fresh Highs: Is There Still Room to Run?

2018-05-30 zacks
Have you been paying attention to shares of Vishay Precision Group (VPG - Free Report) ? Shares have been on the move with the stock up 31.3% over the past month. VPG hit a new 52-week high of $37.40 in the previous session. Vishay Precision Group has gained 47.7% since the start of the year compared to the 4.8% move for the Computer and Technology sector and the -2.9% year-to-date return for its peer group.
VPG.WI RTEC MU SCVL GDI OSIS NOVT VPG

3
Vishay Precision (VPG) Investor Presentation - Slideshow

2018-05-17 seekingalpha
The following slide deck was published by Vishay Precision Group, Inc. in conjunction with this event.
VPG.WI VPG

3
Vishay Precision Group's (VPG) CEO Ziv Shoshani on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Vishay Precision Group, Inc. (NYSE:VPG) Q1 2018 Earnings Conference Call May 8, 2018 10:00 AM ET
VPG.WI VPG

381
Vishay Precision (VPG) Hits a 52-Week High, Can the Run Continue?

2018-05-11 zacks
Have you been paying attention to shares of Vishay Precision Group (VPG - Free Report) ? Shares have been on the move with the stock up 16.8% over the past month. VPG hit a new 52-week high of $36.20 in the previous session. Vishay Precision Group has gained 42.1% since the start of the year compared to the 6.4% move for the Computer and Technology sector and the -2.3% year-to-date return for its peer group.
VPG.WI RTEC TEL SEDG AAOI NOMD OSIS NOVT VPG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...